Global Stent Delivery System Market Size By Type (Peripheral Stent Delivery system, Vascular Stent Delivery system), By Application (Hospital, Outpatient), By Region, And Segment Forecasts, 2023 to 20...

The Global Stent Delivery System Market was valued at USD 9.1 billion in 2023 and is projected to reach USD 14.6 billion by 2031, growing at a CAGR of 6.2% during the forecast period from 2023 to 2031. The growth of this market is fueled by the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive surgeries, and technological advancements in stent systems. With aging populations and growing incidences of arterial blockages, the demand for efficient and reliable stent delivery systems is on the rise, particularly in emerging economies with rapidly evolving healthcare infrastructure.

Drivers:

1. Rising Incidence of Cardiovascular Diseases:

Heart diseases continue to be the leading cause of death globally. With growing sedentary lifestyles and poor dietary habits, the incidence of coronary artery disease is on the rise, driving the demand for advanced stent delivery systems.

2. Shift Toward Minimally Invasive Procedures:

Minimally invasive surgeries are gaining popularity due to reduced recovery times, lower hospital costs, and lesser complications. Stent delivery systems form a crucial part of these procedures, significantly boosting market growth.

3. Technological Advancements in Stents and Catheter Systems:

Innovations such as bioresorbable stents, dual therapy stents, and drug-eluting stents are improving patient outcomes, contributing to the rapid adoption of newer stent delivery systems worldwide.

Restraints:

1. High Cost of Advanced Stent Systems:

Cutting-edge stent technologies often come with high price tags, limiting their accessibility in low-income regions and placing a financial strain on healthcare providers and patients alike.

2. Risk of Restenosis and Complications:

Despite advancements, stent placement still carries risks such as restenosis (re-narrowing of arteries), thrombosis, or improper deployment, which may hamper widespread adoption.

Opportunity:

1. Expansion in Emerging Markets:

Countries like India, Brazil, and China are witnessing rapid development in healthcare infrastructure, making them lucrative markets for global players aiming to expand their stent product offerings.

2. Growing Geriatric Population:

An aging global population increases the likelihood of chronic heart conditions, boosting the long-term demand for stent placement procedures and delivery systems.

Market by System Type Insights:

Based on system type, the Balloon-Expandable Stent Delivery System segment dominated the market in 2023. This dominance is attributed to its precision, ease of placement, and higher control during deployment. However, the Self-Expanding Stent Delivery System segment is expected to witness faster growth due to its application in tortuous or complex vessels, especially in peripheral artery diseases.

Market by End-use Insights:

In terms of end-use, Hospitals accounted for the largest market share in 2023. Hospitals remain the primary centers for stent procedures, benefiting from high patient footfall, advanced infrastructure, and in-house surgical teams. However, Ambulatory Surgical Centers (ASCs) are projected to grow rapidly, driven by cost-effectiveness and shorter patient stay durations.

Market by Regional Insights:

North America led the global market in 2023, supported by well-established healthcare systems, high awareness levels, and a robust presence of key market players. Asia-Pacific is anticipated to be the fastest-growing region during the forecast period, fueled by increasing healthcare expenditure, favorable government initiatives, and a growing burden of cardiovascular diseases in countries like China and India.

Competitive Scenario:

Prominent players in the Global Stent Delivery System Market include Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical, Cardinal Health, Meril Life Sciences, and MicroPort Scientific Corporation. These companies focus on expanding their product portfolios through innovations, strategic partnerships, and regional expansions.

In 2023, Abbott Laboratories introduced a next-gen bioresorbable stent delivery system with improved vessel compatibility and drug release control.

In 2024, Medtronic acquired a catheter technology startup to enhance precision stent deployment.

In 2025, Boston Scientific announced a clinical trial for a smart stent delivery system integrated with real-time imaging capabilities.

Scope of Work – Global Stent Delivery System Market

Report Metric Details

Market Size (2023) USD 9.1 billion

Projected Market Size (2031) USD 14.6 billion

CAGR (2023–2031) 6.2%

Market Segments System Type (Balloon-Expandable, Self-Expanding), End-Use (Hospitals, ASCs), Region

Growth Drivers Rising cardiovascular disease prevalence, shift to minimally invasive surgery, stent innovations

Opportunities Emerging markets, aging population, outpatient surgical trend

Key Market Developments:

2023: Abbott launched a new balloon-expandable delivery system for its latest-generation stents.

2024: Boston Scientific entered into a partnership with AI firms to develop precision-guided deployment tools.

2025: Terumo Corporation expanded its presence in Southeast Asia with localized manufacturing of stent systems.

FAQs:

1. What is the current market size of the Global Stent Delivery System Market?

The market was valued at USD 9.1 billion in 2023.

2. What is the major growth driver of the Global Stent Delivery System Market?

The key driver is the rising prevalence of cardiovascular diseases and the shift toward minimally invasive treatments.

3. Which is the largest region during the forecast period in the Global Stent Delivery System Market?

North America is expected to maintain the largest market share through 2031.

4. Which segment accounted for the largest market share in the Global Stent Delivery System Market?

The Balloon-Expandable Stent Delivery System segment held the largest share in 2023.

5. Who are the key market players in the Global Stent Delivery System Market?

Key players include Abbott Laboratories, Boston Scientific, Medtronic, Terumo, Biotronik, and others.